Objective:

The article examines why early signs of postpartum psychosis (PPP) can be difficult to detect and whether wearable sensors could help identify changes in sleep, activity, and other measures.

Approach:

• Clinical context: PPP is an uncommon, serious postpartum emergency that can occur without prior psychiatric history. Most postpartum screening questionnaires are designed to detect depression and may not efficiently screen for manic or psychotic symptoms; subtle early signs can also be overlooked.
• Potential monitoring: Wearables could passively track sleep characteristics, rest-activity cycles, and nighttime awakenings, and compare changes with an individual mother’s baseline. The article also discusses possible changes in heart rate or behavior as potential signals.

Key Findings:

• PPP affects approximately 0.1%–0.2% of women after childbirth. Most cases emerge within the first two weeks, though symptoms may arise several months after delivery among women at higher risk.
• Early warning signs can include irritability, insomnia, racing thoughts, mood changes, disorientation, and disorganized thinking; these may be normalized as part of adjusting to a newborn.
• Wearables could help distinguish an individual’s concerning sleep or activity changes from routine newborn-related disruption, but this is a potential use, not an established screening method.
• A study in nonpregnant people with bipolar disorder associated more frequent heart-rate changes with manic states; this is not direct evidence that wearables can detect PPP.

Interpretation:

Wearables could help identify individual changes in sleep, activity, or other measures that may precede PPP, but the article states that further research is needed before real-world adoption.

Limitations:

• PPP is unpredictable and can present differently across individuals, including without known risk factors or early signs.
• Sleep disruption is common after childbirth, and its significance may vary with an individual’s prior sleep patterns, complicating interpretation.
• The cited heart-rate study involved nonpregnant people with bipolar disorder, not postpartum women with PPP.
• The article describes wearable monitoring as a possibility and states that additional research is needed before real-world use.